Research and Development
Science That Unlocks Outcomes
Keenova’s research and development is built on scientific depth, regulatory strategy, and operational quality. We advance targeted treatments with a disciplined approach to safety, efficacy, and patient relevance.
A Method Built for Impact
Our R&D strategy integrates deep scientific expertise, real-world data, and active regulatory engagement to develop treatments that help patients manage their conditions and pursue better health.
Clinical Development
We develop investigational and approved therapies with a focus on safety, quality, and patient impact through every stage of product lifecycle.
R&D Operations
With a commitment to quality, safety, and ethics, we follow Good Clinical Practices including ICH E6 guidance, train our team annually, review all protocols through a dedicated committee, and proactively manage risks from planning through execution.
Medical Affairs
Our team aims for excellence in medical strategy, meaningful interactions with thought leaders, and scientific communication that expands medical knowledge.
Regulatory Affairs
With expert oversight, thoughtful exchanges with the FDA and other regulatory agencies, and clear and unwavering processes, we navigate the pharmaceutical regulatory landscape with a commitment to compliance and standards that protect patients.
Safety Standards and Monitoring
Safety is our top priority throughout the product lifecycle, with rigorous clinical trials, clearly communicated medical information, and careful tracking and reporting processes.
Driving What’s Next
Our pipeline reflects our targeted innovations across therapeutic categories. We prioritize research where unmet needs, technical expertise, and patient support intersect.
Orthopedics
XIAFLEX® (collagenase clostridium histolyticum)
Plantar Fibromatosis
Plantar Fasciitis
Hepatology
TERLIVAZ® (terlipressin) vasopressin analog
Hepatorenal syndrome-acute kidney injury (HRS-AKI), Japan
*Products and indications listed here are not currently approved by FDA. For full prescribing information for approved products and indications, please visit the products page.
Clinical Research Strength in Action
Collaborating with physicians at clinical sites, we conduct clinical trials to forge new paths of knowledge and develop tomorrow’s treatments.
Trial Conduct
We run clinical trials with a dedication to the highest quality and patient safety standards, including compliance with current Good Clinical Practices and International Council for Harmonisation guidelines.
Site Partnership
Our team engages clinical trial sites to build meaningful relationships and support site needs. We are proud to be a partner of choice for these clinical experts.
Industry Leadership
Through involvement and leadership in clinical research, we play a role in upholding best practices and moving the industry forward.
Continuous Improvement
We constantly challenge ourselves to do better. Our clinical team applies critical thinking and a continuous improvement mindset to advance capabilities, streamline processes, and integrate insights from patients and clinical sites.
Clinical Trials and Results
We champion transparency and integrity in scientific communication. At Keenova, we proudly register all applicable clinical trials on clinicaltrials.gov, as well as follow ex-US registry requirements, consistently provide status updates, and share study outcomes.
Upon completion of each clinical trial, we are committed to advancing knowledge by publishing meaningful results through respected scientific channels—empowering the broader research community and reinforcing our dedication to responsible innovation.
Advancing New Research
We support investigator-led research and independent education that aligns with our focus areas.
To submit requests for funding of Independent Medical Education (IME) Grants, Fellowships, Investigator-Initiated Research (IIR), Collaborative Research (CR), and Publication-related support grants, please click on the appropriate portal below.
For work related to nitric oxide, immunology, and complications of cirrhosis, go here.
Investigator-Initiated Research
We welcome proposals that explore new hypotheses or expand on existing clinical data within our therapeutic areas.
Independent Medical Education
We offer funding opportunities for CME, symposia, and educational programs that promote responsible, peer-reviewed medical knowledge.
